Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape (Englisch)
- Neue Suche nach: Jamieson, Amy
- Neue Suche nach: Barroilhet, Lisa M.
- Neue Suche nach: McAlpine, Jessica N.
- Neue Suche nach: Jamieson, Amy
- Neue Suche nach: Barroilhet, Lisa M.
- Neue Suche nach: McAlpine, Jessica N.
In:
Cancer
;
128
, 15
;
2853-2857
;
2022
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape
-
Beteiligte:
-
Erschienen in:Cancer ; 128, 15 ; 2853-2857
-
Verlag:
-
Erscheinungsdatum:01.08.2022
-
Format / Umfang:5 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 128, Ausgabe 15
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 2841
-
Issue Information| 2022
- 2850
-
First person profile: Monica Morrow, MD| 2022
- 2851
-
Breast arterial calcification is a risk factor for cardiovascular disease| 2022
- 2852
-
Trastuzumab deruxtecan beats trastuzumab emtansine in lowered disease progression, death| 2022
- 2853
-
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscapeJamieson, Amy / Barroilhet, Lisa M. / McAlpine, Jessica N. et al. | 2022
- 2858
-
Current prostate cancer screening and treatment strategies may not support a holistic nationwide programNnate, Daniel A. / Ball, Jacquie et al. | 2022
- 2865
-
State legislative trends related to biomarker testingSadigh, Gelareh / Goeckner, Hilary Gee / Kazerooni, Ella A. / Johnson, Bruce E. / Smith, Robert A. / Adams, Devon V. / Carlos, Ruth C. et al. | 2022
- 2871
-
Multidisciplinary integrated care pathway for von Hippel–Lindau diseaseWolters, Wendy P. G. / Dreijerink, Koen M. A. / Giles, Rachel H. / van der Horst‐Schrivers, Anouk N. A. / van Nesselrooij, Bernadette / Zandee, Wouter T. / Timmers, Henri J. L. M. / Seute, Tatjana / de Herder, Wouter W. / Verrijn Stuart, Annemarie A. et al. | 2022
- 2880
-
A bridge over troubled water—Extending induction for high‐risk neuroblastoma patients with poor end‐of‐induction responseFederico, Sara M. / Cash, Thomas et al. | 2022
- 2883
-
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor SyndromeHoxhaj, Alma / Drissen, Meggie M.C.M. / Vos, Janet R. / Bult, Peter / Mann, Ritse M. / Hoogerbrugge, Nicoline et al. | 2022
- 2892
-
Adjuvant immunotherapy in patients with high‐risk muscle‐invasive urothelial carcinoma: The potential impact of informative censoringMartini, Alberto / Yu, Menggang / Raggi, Daniele / Joshi, Himanshu / Fallara, Giuseppe / Montorsi, Francesco / Necchi, Andrea / Galsky, Matthew D. et al. | 2022
- 2898
-
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysisNero, Camilla / Pasciuto, Tina / Cappuccio, Serena / Corrado, Giacomo / Pelligra, Silvia / Zannoni, Gian Franco / Santoro, Angela / Piermattei, Alessia / Minucci, Angelo / Lorusso, Domenica et al. | 2022
- 2908
-
Clinical presentation and outcome of human papillomavirus‐positive nasopharyngeal carcinoma in a North American cohortHuang, Shao Hui / Jacinto, J. C. Kennetth / O’Sullivan, Brian / Su, Jie / Kim, John / Ringash, Jolie / Spreafico, Anna / Yu, Eugene / Perez‐Ordonez, Bayardo / Weinreb, Ilan et al. | 2022
- 2922
-
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemiaLoke, Justin / Labopin, Myriam / Craddock, Charles / Cornelissen, Jan J. / Labussière‐Wallet, Hélène / Wagner‐Drouet, Eva Maria / Van Gorkom, Gwendolyn / Schaap, Nicolaas P.M. / Kröger, Nicolaus M. / Veelken, Joan Hendrik et al. | 2022
- 2932
-
First‐line chemotherapy in advanced intra‐abdominal well‐differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysisStacchiotti, Silvia / Van der Graaf, Winette T. A. / Sanfilippo, Roberta G. / Marreaud, Sandrine I. / Van Houdt, Winan J. / Judson, Ian R. / Gronchi, Alessandro / Gelderblom, Hans / Litiere, Saskia / Kasper, Bernd et al. | 2022
- 2939
-
Mortality after multivitamin supplementation: Nearly 35‐year follow‐up of the randomized Linxian Dysplasia Nutrition Intervention TrialFan, Jin‐Hu / Wang, Jian‐Bing / Yang, Huan / Dawsey, Sanford M. / Taylor, Philip R. / Qiao, You‐Lin / Abnet, Christian C. et al. | 2022
- 2949
-
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumorsTakagi, Masatoshi / Ogawa, Chitose / Iehara, Tomoko / Aoki‐Nogami, Yuki / Ishibashi, Eri / Imai, Minoru / Kimura, Toshimi / Nagata, Masashi / Yasuhara, Masato / Masutani, Mitsuko et al. | 2022
- 2958
-
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancerYu, Kenneth H. / Park, Jennifer / Mittal, Avni / Abou‐Alfa, Ghassan K. / El Dika, Imane / Epstein, Andrew S. / Ilson, David H. / Kelsen, David P. / Ku, Geoffrey Y. / Li, Jia et al. | 2022
- 2967
-
Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual diseaseDesai, Ami V. / Applebaum, Mark A. / Karrison, Theodore G. / Oppong, Akosua / Yuan, Cindy / Berg, Katherine R. / MacQuarrie, Kyle / Sokol, Elizabeth / Hall, Anurekha G. / Pinto, Navin et al. | 2022
- 2978
-
Frailty and risk of mortality in older cancer survivors and adults without a cancer history: Evidence from the National Health and Nutrition Examination Survey, 1999‐2014Zhang, Dongyu / Mobley, Erin M. / Manini, Todd M. / Leeuwenburgh, Christiaan / Anton, Stephen D. / Washington, Caretia J. / Zhou, Daohong / Parker, Alexander S. / Okunieff, Paul G. / Bian, Jiang et al. | 2022
- 2988
-
How should decision aids be developed, and which patient outcomes should be assessed?Diefenbach, Michael A. / Miller, Suzanne M. et al. | 2022
- 2990
-
Reply to “How should decision aids be developed, and which patient outcomes should be assessed?”Kim, Simon P. / Tilburt, Jon C. et al. | 2022
- 2991
-
Cancer treatment in the time of COVID‐19 pandemics: A new concernNasrollahi, Hamid / Molavi Vardanjani, Hossein / Pasalar, Mehdi et al. | 2022
- 2992
-
Reply to “Cancer treatment in the time of COVID‐19 pandemics: A new concern”Englum, Brian R. / Prasad, Nikhil K. / Turner, Douglas J. / Sorkin, John D. / Lal, Brajesh K. et al. | 2022
- 2994
-
Noncancer comparators in cancer survivorship studiesChubak, Jessica / Lund, Jennifer L. et al. | 2022
- 2995
-
Reply to “Noncancer comparators in cancer survivorship studies”Kobayashi, Lindsay C. / Westrick, Ashly C. / Doshi, Aalap / Ellis, Katrina R. / Jones, Carly R. / LaPensee, Elizabeth / Mondul, Alison M. / Mullins, Megan A. / Wallner, Lauren P. et al. | 2022
- 2997
-
Neither tamoxifen nor aromatase inhibitors increase the risk of Parkinson disease in the UK Biobank cohortLehrer, Steven / Rheinstein, Peter H. et al. | 2022
- 2999
-
Vitamin D and breast cancer: Stop torturing the data!Braillon, Alain et al. | 2022
- 3000
-
Reply to “Vitamin D and breast cancer: Stop torturing the data!”O'Brien, Katie M. / Sandler, Dale P. et al. | 2022